IDO1 and myeloid sarcoma: Moreover, an opposing pattern of IDO and IFN-γ mRNA expression was observed in spinal cord and peripheral blood mononuclear cells (PBMCs) through the preclinical, acute and remission phases of EAE [12], suggesting that IDO and Trp metabolites contribute to the reversible neurological symptoms of MS.